Hyperglycaemia and advanced glycation end products (AGEs) were reported to down‐regulate the expression of miR‐133a and then aggravate apoptotic susceptibility of VSMCs via inhibiting insulin growth factor 1 receptor (IGFR‐1R) activity and activation of NF‐κB. The gene discussed is NFKB1; the disease is Hyperglycemia.